| Deficiency of smooth muscle cell ILF3 alleviates intimal hyperplasia via HMGB1 mRNA degradation-mediated regulation of the STAT3/DUSP16 axis. | Deficiency of smooth muscle cell ILF3 alleviates intimal hyperplasia via HMGB1 mRNA degradation-mediated regulation of the STAT3/DUSP16 axis.
Hou YM, Xu BH, Zhang QT, Cheng J, Zhang X, Yang HR, Wang ZY, Wang P, Zhang MX. | 05/1/2024 |
| Role of ATF3 triggering M2 macrophage polarization to protect against the inflammatory injury of sepsis through ILF3/NEAT1 axis. | Role of ATF3 triggering M2 macrophage polarization to protect against the inflammatory injury of sepsis through ILF3/NEAT1 axis.
Wang W, Xu R, He P, Xiong Y, Zhao H, Fu X, Lin J, Ye L., Free PMC Article | 03/8/2024 |
| Astragaloside IV promotes keratinocyte proliferation and migration through upregulating lncRNA H19 recruited ILF3 to enhance the stability of CDK4 mRNA. | Astragaloside IV promotes keratinocyte proliferation and migration through upregulating lncRNA H19 recruited ILF3 to enhance the stability of CDK4 mRNA.
Wang DD, Zhang LZ, Pang CJ, Ye JZ. | 08/16/2023 |
| E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA. | E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA.
Shen HM, Zhang D, Xiao P, Qu B, Sun YF., Free PMC Article | 07/21/2023 |
| PSMD3-ILF3 signaling cascade drives lung cancer cell proliferation and migration. | PSMD3-ILF3 signaling cascade drives lung cancer cell proliferation and migration.
Zhang J, Ma Q, Yu Q, Xiao F, Zhang Z, Feng H, Liang C., Free PMC Article | 06/23/2023 |
| Genome-wide CRISPR screens identify ILF3 as a mediator of mTORC1-dependent amino acid sensing. | Genome-wide CRISPR screens identify ILF3 as a mediator of mTORC1-dependent amino acid sensing.
Yan G, Yang J, Li W, Guo A, Guan J, Liu Y. | 05/17/2023 |
| Prognostic and immunotherapeutic predictive value of interleukin enhancer-binding factor 3 in hepatocellular carcinoma: Integrated bioinformatics and experimental analysis. | Prognostic and immunotherapeutic predictive value of interleukin enhancer-binding factor 3 in hepatocellular carcinoma: Integrated bioinformatics and experimental analysis.
Qiu J, Wu X, Luo Y, Yao Y, Zhang X, Pan B, Wang X, Tang N. | 02/4/2023 |
| Hsa_circ_0005050 interacts with ILF3 and affects cell apoptosis and proliferation by disrupting the balance between p53 and p65. | Hsa_circ_0005050 interacts with ILF3 and affects cell apoptosis and proliferation by disrupting the balance between p53 and p65.
Tan J, Sun M, Yin J, Zhou Q, Zhao R, Chen Q, Sun H, Jiang C, Li S, He Y. | 12/3/2022 |
| RNA binding protein POP7 regulates ILF3 mRNA stability and expression to promote breast cancer progression. | RNA binding protein POP7 regulates ILF3 mRNA stability and expression to promote breast cancer progression.
Huang Y, Zheng Y, Yao L, Qiao F, Hou Y, Hu X, Li D, Shao Z., Free PMC Article | 11/12/2022 |
| NF90 interacts with components of RISC and modulates association of Ago2 with mRNA. | NF90 interacts with components of RISC and modulates association of Ago2 with mRNA.
Grasso G, Akkawi C, Franckhauser C, Nait-Saidi R, Bello M, Barbier J, Kiernan R., Free PMC Article | 09/17/2022 |
| ILF3 represses repeat-derived microRNAs targeting RIG-I mediated type I interferon response. | ILF3 represses repeat-derived microRNAs targeting RIG-I mediated type I interferon response.
Chen G, Yang Y, Wu QJ, Cao L, Ruan W, Shao C, Jiang L, Tang P, Ma S, Jiang A, Wang Z, Wu K, Zhang QC, Fu XD, Zhou Y. | 05/14/2022 |
| ILF3 is responsible for hyperlipidemia-induced arteriosclerotic calcification by mediating BMP2 and STAT1 transcription. | ILF3 is responsible for hyperlipidemia-induced arteriosclerotic calcification by mediating BMP2 and STAT1 transcription.
Xie F, Cui QK, Wang ZY, Liu B, Qiao W, Li N, Cheng J, Hou YM, Dong XY, Wang Y, Zhang MX. | 03/19/2022 |
| Systematic identification of NF90 target RNAs by iCLIP analysis. | Systematic identification of NF90 target RNAs by iCLIP analysis.
Lodde V, Floris M, Munk R, Martindale JL, Piredda D, Napodano CMP, Cucca F, Uzzau S, Abdelmohsen K, Gorospe M, Noh JH, Idda ML., Free PMC Article | 01/29/2022 |
| Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an m(6)A-dependent manner. | Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an m(6)A-dependent manner.
Bo C, Li N, He L, Zhang S, An Y. | 01/29/2022 |
| Upregulated long noncoding RNA LincIN promotes tumor progression via the regulation of nuclear factor 90/microRNA7/HOXB13 in esophageal squamous cell carcinoma. | Upregulated long non‑coding RNA LincIN promotes tumor progression via the regulation of nuclear factor 90/microRNA‑7/HOXB13 in esophageal squamous cell carcinoma.
Tan Z, Zhou P, Zhu Z, Wang Y, Guo Z, Shen M, Xiao Y, Shen W, Wu D., Free PMC Article | 11/13/2021 |
| HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA. | HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.
Jiang F, Tang X, Tang C, Hua Z, Ke M, Wang C, Zhao J, Gao S, Jurczyszyn A, Janz S, Beksac M, Zhan F, Gu C, Yang Y., Free PMC Article | 09/18/2021 |
| circACTA2 mediates Ang II-induced VSMC senescence by modulation of the interaction of ILF3 with CDK4 mRNA. | circACTA2 mediates Ang II-induced VSMC senescence by modulation of the interaction of ILF3 with CDK4 mRNA.
Ma Y, Zheng B, Zhang XH, Nie ZY, Yu J, Zhang H, Wang DD, Shi B, Bai Y, Yang Z, Wen JK., Free PMC Article | 07/31/2021 |
| TMEM98 mRNA promotes proliferation and invasion of gastric cells by directly interacting with NF90 protein. | TMEM98 mRNA promotes proliferation and invasion of gastric cells by directly interacting with NF90 protein.
Ao X, Li X, Chen Y, Zang Z, Guo W, Liang J. | 06/26/2021 |
| ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer. | ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer.
Li K, Wu JL, Qin B, Fan Z, Tang Q, Lu W, Zhang H, Xing F, Meng M, Zou S, Wei W, Chen H, Cai J, Wang H, Zhang H, Cai J, Fang L, Bian X, Chen C, Lan P, Ghesquière B, Fang L, Lee MH., Free PMC Article | 05/29/2021 |
| NF45 and NF90 Regulate Mitotic Gene Expression by Competing with Staufen-Mediated mRNA Decay. | NF45 and NF90 Regulate Mitotic Gene Expression by Competing with Staufen-Mediated mRNA Decay.
Nourreddine S, Lavoie G, Paradis J, Ben El Kadhi K, Méant A, Aubert L, Grondin B, Gendron P, Chabot B, Bouvier M, Carreno S, Roux PP. | 05/22/2021 |
| LncRNA MEG3 contributes to adenosine-induced cytotoxicity in hepatoma HepG2 cells by downregulated ILF3 and autophagy inhibition via regulation PI3K-AKT-mTOR and beclin-1 signaling pathway. | LncRNA MEG3 contributes to adenosine-induced cytotoxicity in hepatoma HepG2 cells by downregulated ILF3 and autophagy inhibition via regulation PI3K-AKT-mTOR and beclin-1 signaling pathway.
Pu Z, Wu L, Guo Y, Li G, Xiang M, Liu L, Zhan H, Zhou X, Tan H. | 09/19/2020 |
| NF90 modulates processing of a subset of human pri-miRNAs. | NF90 modulates processing of a subset of human pri-miRNAs.
Grasso G, Higuchi T, Mac V, Barbier J, Helsmoortel M, Lorenzi C, Sanchez G, Bello M, Ritchie W, Sakamoto S, Kiernan R., Free PMC Article | 09/12/2020 |
| NF90 contributes to repressing the immune response in cells responding to P. falciparum infection. | NF90 regulation of immune factor expression in response to malaria antigens.
Idda ML, Lodde V, Galleri G, Martindale JL, Munk R, Abdelmohsen K, Cucca F, Gorospe M., Free PMC Article | 04/18/2020 |
| NF90 regulates HIF-1alpha/VEGF-A expression through the PI3K/Akt signaling pathway to promote angiogenesis in cervical cancer. | Nuclear factor 90 promotes angiogenesis by regulating HIF-1α/VEGF-A expression through the PI3K/Akt signaling pathway in human cervical cancer.
Zhang W, Xiong Z, Wei T, Li Q, Tan Y, Ling L, Feng X., Free PMC Article | 04/11/2020 |
| The dsRNA binding protein ILF3 as an essential host factor required for efficient translation of the central antiviral cytokine, IFNB1, and a subset of interferon-stimulated genes. | ILF3 contributes to the establishment of the antiviral type I interferon program.
Watson SF, Bellora N, Macias S., Free PMC Article | 03/21/2020 |